Related Experiment Video
Updated: Aug 9, 2026

Prostaglandin Extraction and Analysis in Caenorhabditis elegans
Published on: June 25, 2013
Role of p21 in prostaglandin A2-mediated cellular arrest and death
1Section on Gene Expression and Aging, National Institute on Aging, NIH, Baltimore, Maryland 21224, USA.
Abstract:
Prostaglandin A2 (PGA2) treatment induces growth arrest of most cells, and we have recently shown that, for breast carcinoma MCF-7 cells, this is correlated with an induction of the cyclin-dependent kinase inhibitor p21 and reduced cyclin-dependent kinase 2 activity. In this study, we demonstrate that, in RKO cells, PGA2 treatment fails to induce growth arrest, but rather results in significant cell death. These effects are correlated with lack of p21 induction and enhanced cyclin-dependent kinase 2 activity. Reduction of endogenous p21 expression in MCF-7 cells through expression of antisense p21 resulted in a response pattern approaching that seen in RKO cells, characterized by diminished growth arrest and increased death. These findings support a role for p21 in PGA2-mediated growth arrest, which we propose serves to prevent cell death caused by inappropriate cell cycle progression.
Insights
Prostaglandin A2 (PGA2) causes growth arrest in some cells by increasing p21, but triggers cell death in others. Lack of p21 leads to cell death, suggesting p21 prevents death from cell cycle issues.
Area of Science:
- Cell Biology
- Molecular Biology
- Cancer Research
Background:
- Prostaglandin A2 (PGA2) is known to induce growth arrest in various cell types.
- Previous studies linked PGA2-induced growth arrest in MCF-7 breast cancer cells to p21 induction and decreased cyclin-dependent kinase 2 (CDK2) activity.
Purpose of the Study:
- To investigate the differential cellular response of RKO cells to PGA2 compared to MCF-7 cells.
- To elucidate the role of p21 in mediating PGA2's effects on cell cycle progression and cell death.
Main Methods:
- Treatment of RKO and MCF-7 cells with Prostaglandin A2 (PGA2).
- Analysis of p21 expression levels and cyclin-dependent kinase 2 (CDK2) activity.
- Manipulation of endogenous p21 expression in MCF-7 cells using antisense p21.
Main Results:
- PGA2 treatment failed to induce growth arrest in RKO cells, leading to significant cell death.
- RKO cells showed no p21 induction and increased CDK2 activity following PGA2 treatment.
- Reducing p21 in MCF-7 cells mimicked the RKO cell response, causing less growth arrest and more cell death.
Conclusions:
- The cyclin-dependent kinase inhibitor p21 plays a crucial role in mediating Prostaglandin A2-induced growth arrest.
- p21 induction by PGA2 appears to prevent inappropriate cell cycle progression and subsequent cell death.
- Differential p21 expression contributes to varied cellular responses to PGA2, impacting cell fate.
More Related Videos
15:53Cell Death Associated with Abnormal Mitosis Observed by Confocal Imaging in Live Cancer Cells
Published on: August 21, 2013
09:18Identification of Intracellular Signaling Events Induced in Viable Cells by Interaction with Neighboring Cells Undergoing Apoptotic Cell Death
Published on: December 27, 2016
Related Concept Videos
Negative Regulator Molecules
Inhibition of Cdk Activity
Abnormal Proliferation
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Amplifying Signals via Enzymatic Cascade
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...